drugset / Trial / NCT01408069
Non-Inferiority Comparison of Migrane® Versus Parcel ® For Treatment of Tensional Cephaleia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different associations of drugs in the treatment of patients diagnosed with tensional-type headache in accordance with International Headache Society guidelines.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped (Business): “Study canceled by decision strategically.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | 450 mg | — |
| Subject | Caffeine | Small molecule | 40 mg | — |
| Subject | Caffeine | Small molecule | 100 mg | — |
| Subject | acetylsalicylic | Unknown | 350 mg | — |
| Subject | homatropine | Small molecule | 1.2 mg | — |
| Comparator | ergotamine | Small molecule | 1 mg | — |
Indications
No indication recorded.